Lv11
50 积分 2024-11-29 加入
Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets
1小时前
已完结
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
1小时前
已完结
Sevoflurane suppresses NLRP3 inflammasome-mediated pyroptotic cell death to attenuate lipopolysaccharide-induced acute lung injury through inducing GSK-3β phosphorylation and activation
9天前
已完结
Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors
11天前
已完结
Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors
15天前
已完结
NLRP3 inflammasome in cancer and metabolic diseases
19天前
已完结
Non-coding RNAs: The key regulators in NLRP3 inflammasome-mediated inflammatory diseases
1个月前
已完结
Functional crosstalk between Long non-coding RNAs and the NLRP3 inflammasome in the regulation of diseases
1个月前
已完结
Engineering of VCAM-1-targeted nanostructured lipid carriers for delivery of melatonin against acute lung injury through SIRT1/NLRP3 mediated pyroptosis signaling pathway
1个月前
已完结
Peficitinib alleviated acute lung injury by blocking glycolysis through JAK3/STAT3 pathway
1个月前
已完结
皖公网安备34019202002308
